Join our EHA 2026 highlights webinar
Latest news
To help patients and advocates digest the most important myeloma news from the European Hematology Association (EHA) 2026 Annual Congress, the largest haematology event in Europe, Myeloma Patients Europe (MPE) will host a webinar on Tuesday, 30 June at 17:00 CET.
At this webinar you can expect clear explanations of the key research updates and what they could mean for patients. You’ll also hear expert insights and have the chance to ask any questions you may have using Zoom’s Q&A Function.
Whether you’re a patient, carer, or advocate, this webinar will help you stay informed and increase your understanding about the latest advances in myeloma treatment and research.
The session will be led by Sweden’s Dr. Johan Lund.
Meet the speaker
Dr. Johan Lund is a senior consultant and affiliated researcher at the Department of Medicine at Karolinska Institutet in Stockholm, Sweden. His publications focus on hematology, particularly multiple myeloma, stem cell transplantation, cellular therapies and immunotherapy. He is affiliated with both the Hematological and Solid Tumors research group and the Cell and Gene Therapy research group at Karolinska Institutet. He obtained a PhD from the Department of Medicine, Huddinge, Karolinska Institutet, in 2016.
